A pilot study of paternal drug exposure: The Motherisk experience

Reproductive Toxicology

Volumn 29, Issue 3, 2010, Pages 353-360

  Lee, Candace Y W ^a   Jin, Cheng ^a   Mata, Andrea M ^a   Tanaka, Toshihiro ^a   Einarson, Adrienne ^a   Koren, Gideon ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Canada; Motherisk; Paternal exposure; Teratology information service

Indexed keywords

ACETYLSALICYLIC ACID DERIVATIVE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL STIMULANT AGENT; CITALOPRAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FINASTERIDE; HORMONE ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPNOTIC AGENT; IMMUNOMODULATING AGENT; METHOTREXATE; NEUROLEPTIC AGENT; PHOSPHODIESTERASE V INHIBITOR; PREDNISONE; PREGABALIN; PROTON PUMP INHIBITOR; RETINOIC ACID DERIVATIVE; SEDATIVE AGENT; UNINDEXED DRUG;

ADULT; ARTICLE; COHORT ANALYSIS; CONGENITAL MALFORMATION; CONSULTATION; COUNSELING; DRUG EXPOSURE; DRUG SAFETY; EXPERIENCE; FATHER; FEMALE; HUMAN; LACTATION; MAJOR CLINICAL STUDY; MALE; MOTHER; PILOT STUDY; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDY; RISK ASSESSMENT; SPONTANEOUS ABORTION; TELEPHONE;

AZATHIOPRINE; BREAST FEEDING; COHORT STUDIES; COUNSELING; DATABASES, FACTUAL; FEMALE; HUMANS; LACTATION; MALE; METHOTREXATE; PATERNAL EXPOSURE; PHARMACEUTICAL PREPARATIONS; PILOT PROJECTS; PREGNANCY; RETROSPECTIVE STUDIES; TELEPHONE; TERATOLOGY;

EID: 77951533032     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2010.01.008     Document Type: Article

References (16)

1. Organization of Teratology Information Specialists Paternal exposures and pregnancy 2002, [accessed August 28, 2008]. Available at. http://otispregnancy.org/pdf/paternal.pdf.
2. Schirm E., Pedersen L., Tobi H., Nielsen G.L., Sorensen H.T., de Jong-van den Berg L.T. Drug use among fathers around time of conception: two register based surveys from Denmark and The Netherlands. Pharmacoepidemiol Drug Saf 2004, 13:609-613.
3. Cordier S. Evidence for a role of paternal exposures in developmental toxicity. Basic Clin Pharmacol Toxicol 2008, 102:176-181.
4. Sokol G., Krasnow R., Knudsen J., Biade S., Cantilena L. Investigational drug research and testicular/spermatocytic function: ethical considerations. J Clin Pharmacol 2008, 48:1105. [abst].
5. Jenkins K.J., Correa A., Feinstein J.A., Botto L., Britt A.E., Daniels S.R., et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007, 115:2995-3014.
6. French A.E., Koren G. Effect of methotrexate on male fertility. Can Fam Physician 2003, 49:577-578.
7. Hoeltzenbein M., Weber-Schoendorfer C., von Stackelberg L., Schaefer C. Paternal exposure to drugs-is there an increased risk for congenital abnormalities?: experience of the Berlin Institute for Clinical Teratology and Drug Risk Assessment during Pregnancy. Reprod Toxicol 2008, 26:64. [abst].
8. De Santis M., Cesari E., Cavaliere A., Ligato M.S., Nobili E., Visconti D., et al. Paternal exposure and counselling: experience of a teratology information service. Reprod Toxicol 2008, 26:42-46.
9. Koren G., Feldman Y., Shear N. Motherisk-a new approach to antenatal counselling of drug/chemical exposure. Vet Hum Toxicol 1986, 28:563-565.
10. Taguchi N., Ito S. Paternal use of ribavirin-interferon alpha 2B combination therapy before conception. Can Fam Physician 2005, 51:1623-1625.
11. Moretti M.E. Motherisk: the Toronto model for counselling in reproductive toxicology. Medication safety in pregnancy and breastfeeding 2007, 295-307. McGraw-Hill, New York. G. Koren (Ed.).
12. Goodman & Gilman's The pharmacological basis of therapeutics 2006, McGraw-Hill, New York. 11th ed.
13. Grunewald S., Paasch U., Glander H.J. Systemic dermatological treatment with relevance for male fertility. J Dtsch Dermatol Ges 2007, 5:15-21.
14. Kalb R.E., Strober B., Weinstein G., Lebwohl M. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol 2009, 60:824-837.
15. Gurgan T., Salman C., Demirol A. Pregnancy and assisted reproduction techniques in men and women after cancer treatment. Placenta 2008, 29:S152-S159.
16. AbdelHafez F., Bedaiwy M., El-Nashar S.A., Sabanegh E., Desai N. Techniques for cryopreservation of individual or small numbers of human spermatozoa: a systematic review. Hum Reprod Update 2009, 15:153-164.